checkAd

     129  0 Kommentare Innovation Pharmaceuticals Announces Topline Results from Phase 2 Clinical Trial of Brilacidin for COVID-19 - Seite 3

    INVESTOR AND MEDIA CONTACTS:

    Innovation Pharmaceuticals Inc.
    Leo Ehrlich
    info@ipharminc.com

    Lesen Sie auch

    SOURCE: Innovation Pharmaceuticals



    View source version on accesswire.com:
    https://www.accesswire.com/672330/Innovation-Pharmaceuticals-Announces ...


    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Accesswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Innovation Pharmaceuticals Announces Topline Results from Phase 2 Clinical Trial of Brilacidin for COVID-19 - Seite 3 WAKEFIELD, MA / ACCESSWIRE / November 11, 2021 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today reported topline results from the Company's Phase 2 clinical trial of Brilacidin in …